They also stalled their review of French drugmaker Sanofi's Tzield for late-stage type 1 diabetes by more than a month over ...
As many as four decisions under the US Food and Drug Administration’s (FDA) new fast-track program have been delayed, Reuters ...
The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
Extended half-life products for children with hemophilia B reduce both bleeding episodes and the need for infusions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback